The Valley Desk

NCT00382993 · Interventional trial

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Overall registry status Completed

Phase 3

Conditions Migraine Disorders

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov